US 10072084
Dual specific immunotoxin for brain tumor therapy
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10072084 (Dual specific immunotoxin for brain tumor therapy) held by The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary Department of Health and Human Services (NIH)
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K38/00, A61K39/39558